28389361|t|Annexin A1 nuclear translocation induces retinal ganglion cell apoptosis after ischemia-reperfusion injury through the p65/IL-1β pathway
28389361|a|The degeneration of retinal ganglion cells (RGCs) has been identified as a major problem in glaucoma. Previous studies have indicated an association between annexin A1 (ANXA1) and neuronal cell apoptosis, and RGCs apoptosis in acute ischemia-reperfusion was attributed to an increased production of IL-1β. We found that the expression and nuclear translocation of ANXA1 were upregulated in models of acute ischemia-reperfusion in RGCs in vivo. ANXA1 was found to have a promoting effect on the expression of IL-1β in primary cultured RGCs, which could be inhibited by treatment with ANXA1 shRNA or the p65 inhibitor BAY 11-7082. ANXA1 interacted with p65, and recruited it into the nucleus. Chromatin immunoprecipitation assay revealed that ANXA1 accumulated at the IL-1β gene promoter. The reduction of p65 nuclear translocation using a membrane-permeable ANXA1 peptide containing a Ser5Ala mutation led to a decrease in the expression of IL-1β, and acute ischemia-reperfusion induced RGCs apoptosis in vivo. These results indicate that in RGCs, ANXA1 increases IL-1β expression by recruiting p65 to the nucleus, which induces cell apoptosis. The obtained results may help the development of a novel treatment strategy against RGCs apoptosis in acute ischemia-reperfusion injury.
28389361	0	10	Annexin A1	T103	UMLS:C0103403
28389361	11	32	nuclear translocation	T038	UMLS:C1518440
28389361	41	62	retinal ganglion cell	T017	UMLS:C0035316
28389361	63	72	apoptosis	T038	UMLS:C0162638
28389361	79	106	ischemia-reperfusion injury	T037	UMLS:C0349419
28389361	141	153	degeneration	T038	UMLS:C0011164
28389361	157	179	retinal ganglion cells	T017	UMLS:C0035316
28389361	181	185	RGCs	T017	UMLS:C0035316
28389361	229	237	glaucoma	T038	UMLS:C0017601
28389361	294	304	annexin A1	T103	UMLS:C0103403
28389361	306	311	ANXA1	T103	UMLS:C0103403
28389361	317	340	neuronal cell apoptosis	T038	UMLS:C1660771
28389361	346	350	RGCs	T017	UMLS:C0035316
28389361	351	360	apoptosis	T038	UMLS:C0162638
28389361	370	390	ischemia-reperfusion	T037	UMLS:C0349419
28389361	436	441	IL-1β	T103	UMLS:C0021753
28389361	461	471	expression	T038	UMLS:C1171362
28389361	476	497	nuclear translocation	T038	UMLS:C1518440
28389361	501	506	ANXA1	T103	UMLS:C0103403
28389361	512	523	upregulated	T038	UMLS:C0041904
28389361	543	563	ischemia-reperfusion	T037	UMLS:C0349419
28389361	567	571	RGCs	T017	UMLS:C0035316
28389361	572	579	in vivo	T082	UMLS:C1515655
28389361	581	586	ANXA1	T103	UMLS:C0103403
28389361	631	641	expression	T038	UMLS:C1171362
28389361	645	650	IL-1β	T103	UMLS:C0021753
28389361	654	670	primary cultured	T058	UMLS:C1449562
28389361	671	675	RGCs	T017	UMLS:C0035316
28389361	720	731	ANXA1 shRNA	T103	UMLS:C2930586
28389361	739	764	p65 inhibitor BAY 11-7082	T103	UMLS:C0969281
28389361	766	771	ANXA1	T103	UMLS:C0103403
28389361	788	791	p65	T103	UMLS:C0599933
28389361	819	826	nucleus	T017	UMLS:C0007610
28389361	828	863	Chromatin immunoprecipitation assay	T058	UMLS:C0020980
28389361	878	883	ANXA1	T103	UMLS:C0103403
28389361	903	913	IL-1β gene	T017	UMLS:C1334112
28389361	914	922	promoter	T103	UMLS:C0033413
28389361	941	966	p65 nuclear translocation	T038	UMLS:C1518440
28389361	994	1007	ANXA1 peptide	T103	UMLS:C0103403
28389361	1021	1037	Ser5Ala mutation	T038	UMLS:C0026882
28389361	1063	1073	expression	T038	UMLS:C1171362
28389361	1077	1082	IL-1β	T103	UMLS:C0021753
28389361	1094	1114	ischemia-reperfusion	T037	UMLS:C0349419
28389361	1123	1127	RGCs	T017	UMLS:C0035316
28389361	1128	1137	apoptosis	T038	UMLS:C0162638
28389361	1138	1145	in vivo	T082	UMLS:C1515655
28389361	1178	1182	RGCs	T017	UMLS:C0035316
28389361	1184	1189	ANXA1	T103	UMLS:C0103403
28389361	1200	1205	IL-1β	T103	UMLS:C0021753
28389361	1206	1216	expression	T038	UMLS:C1171362
28389361	1231	1234	p65	T103	UMLS:C0599933
28389361	1242	1249	nucleus	T017	UMLS:C0007610
28389361	1265	1279	cell apoptosis	T038	UMLS:C0162638
28389361	1338	1356	treatment strategy	T058	UMLS:C0040808
28389361	1365	1369	RGCs	T017	UMLS:C0035316
28389361	1370	1379	apoptosis	T038	UMLS:C0162638
28389361	1389	1416	ischemia-reperfusion injury	T037	UMLS:C0349419